Evolus, Inc. (EOLS) Social Stream
Evolus Inc (EOLS) Price Targets From Analysts
Use the tables below to see what analysts covering Evolus Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 7 | $20 | $7 | $15.142 | $6.66 | 127.36% |
The Trend in the Analyst Price Target
Over the past 39 weeks, EOLS's average price target has gone down $0.86.
EOLS reports an average of 62.79% for its upside potential over the past 19 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-17 | 7 | 20 | 7 | 15.142 | 6.22 | 143.44% |
| 2020-06-04 | NA | 35 | 4 | 14.750 | NA | NA% |
EOLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.86 | 5 | 0 | 1 | 1 | 1 | 7 |
The Trend in the Broker Recommendations
Over the past 122 days, EOLS's average broker recommendation rating improved by 0.39.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- EOLS has a less variance in analysts' estimates than 9.48999999999999% of all US stocks.
- The number of analysts covering the stock of EOLS is higher than 87.54% of stocks in the small market cap category.
- The upside potential (average analyst target price relative to current price) of EOLS is greater than 84.73% of all US stocks.
- Evolus Inc's average analyst price target is greater than 18.05% of all US stocks.
Stocks similar to Evolus Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IFRX, OMER and CTMX.
Is EOLS a Buy, Hold or Sell? See the POWR Ratings now!